Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2014
February 2014
3 Stocks Improving Performance Of The Drugs Industry
3 Stocks Improving Performance Of The Drugs Industry
TheStreet.com
Celgene
Merck
JNJ
Report: Novartis reorganization quietly claims 3,000 jobs in just 4 months
Report: Novartis reorganization quietly claims 3,000 jobs in just 4 months
Fierce Biotech
Novartis
layoffs
reorganization
Analysts cheer on Merck's comeback campaign, pumping up blockbuster forecasts
Analysts cheer on Merck's comeback campaign, pumping up blockbuster forecasts
Fierce Biotech
Merck
MK-3475
Endo loss widens, R&D chief departs amid regulatory struggles
Endo loss widens, R&D chief departs amid regulatory struggles
Fierce Pharma
Endo Health Solutions
earnings
Questcor continues lower as FDA says reviewing Acthar lab test results
Questcor continues lower as FDA says reviewing Acthar lab test results
The Fly on the Wall
Questcor Pharmaceuticals
FDA
Acthar
Generic-Drug Failures Spur Concern as FDA Steps Up Action
Generic-Drug Failures Spur Concern as FDA Steps Up Action
Bloomberg
generics
FDA
Small Is Beautiful? Not Without Biotech
Small Is Beautiful? Not Without Biotech
Barron's
biotech
Intercept Pharma
Merck's NOXAFIL gets positive opinion from CHMP
Merck's NOXAFIL gets positive opinion from CHMP
Yahoo/Fly on the Wall
Merck
CHMP
Noxafil
Europe
Ligand says partner GSK submits application for Promacta
Ligand says partner GSK submits application for Promacta
Yahoo/Fly on the Wall
Ligand Pharmaceuticals
GSK
Promacta
Auxilium Q4 Beats Estimates, But Guidance Cautious
Auxilium Q4 Beats Estimates, But Guidance Cautious
Investors.com
earnings
Auxilium
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »